Mork Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,190
Closed -$1.07M 114
2024
Q4
$1.07M Hold
47,190
0.7% 66
2024
Q3
$1.01M Hold
47,190
0.72% 75
2024
Q2
$901K Hold
47,190
0.71% 79
2024
Q1
$910K Sell
47,190
-4,390
-9% -$87K 0.69% 92
2023
Q4
$1.07M Hold
51,580
0.66% 53
2023
Q3
$1.11M Hold
51,580
0.87% 37
2023
Q2
$1.23M Hold
51,580
0.95% 29
2023
Q1
$1.1M Hold
51,580
0.89% 34
2022
Q4
$843K Buy
+51,580
New +$765K 0.65% 84

Other funds holding FMS

Mork Capital Management's FMS Position: Q1 2025 in Review

Mork Capital Management sold out of Fresenius Medical Care (FMS) in Q1 2025, closing a stake of 47,190 shares — an estimated $1.07M sold.

Mork Capital Management first reported a position in FMS in Q4 2022 and held it in 9 quarters. The position peaked at $1.23M in Q2 2023. 201 funds tracked by Wall St. Rank hold FMS as of Q1 2025.

  • Mork Capital Management reported no remaining Fresenius Medical Care position as of Q1 2025 after selling out during the quarter.
  • Mork Capital Management sold 47,190 Fresenius Medical Care shares in Q1 2025, an estimated $1.07M.
  • Mork Capital Management first reported a position in Fresenius Medical Care in Q4 2022 and held it in 9 quarters.
  • Mork Capital Management's Fresenius Medical Care position peaked at $1.23M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2025.

Based on Mork Capital Management's 13F filing for Q1 2025, filed 15 May 2025.